Clinical Trials for Genome & Company

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Genome & Company

Clinical Trials (1)

NCT05998447
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
PHASE2Recruiting
148 participants
Started: Sep 18, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors6 locations